News-Morimatsu LifeSciences

FROM CRITICAL EQUIPMENT TO
TOTAL PROCESS SOLUTION

BACK

Next-generation vaccines enabled by recombinant protein bioreactors

In the past 2021, Morimatsu has successfully delivered modular factories for COVID-19 vaccines developed via mRNA and adenovirus technology. At the beginning of the new year, we have passed the FAT of the bioreactor system for the recombinant protein enabling COVID-19 vaccines which then are ready f
Use of stainless steel and disposable equipment in biopharmaceutical production

It is well known that the performance of production equipment in the biopharmaceutical industry has a direct impact on product quality and even on the capacity of the entire industry. Stainless steel equipment and disposable equipment are now widely used in biopharmaceutical companies, but wha
Branding “Made in China” with Excellent Quality

The following article is written by Shao Jie for PharmaTECChinaIn 1998, Mr. Nishimatsu Koei, the newly appointed CEO of Morimatsu Shanghai, led the company to a road to profit-making in the years that followed in succession based on his wisdom and providence, his understanding of technology, and his
Good news keeps pouring in∣Commendations from clients in electronic chemical industry

In the past December 2021, Morimatsu successfully delivered a hydrogen peroxide RO module and an IEX module project to a famous European fine chemical company and favorably completed system debugging and feed commissioning. The products had passed quality inspection in one go and conformed to domest
New Challenges Generate New Drivers, High-Quality Bioreactor + Digital Services = New Process

This article is from The Circle of Biological Products In 2020, the COVID-19 epidemic spread relentlessly around the world, a public health emergency that instantly put people around the world on alert. According to Worldometers, as of October 14, 2021 (GMT+8), the total number of con

Prev ···31 32 33 34 35··· Next